# Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke

> **NCT02114736** · PHASE4 · UNKNOWN · sponsor: **University Hospital of Mont-Godinne** · enrollment: 20 (estimated)

## Conditions studied

- Stroke
- Spasticity

## Interventions

- **PROCEDURE:** Tenotomy of the proximal rectus femoris tendon
- **DRUG:** Botulinum Toxin injection in the rectus femoris muscle

## Key facts

- **NCT ID:** NCT02114736
- **Lead sponsor:** University Hospital of Mont-Godinne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114736, "Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02114736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*